- Research works
- 5 fractional, all time
- Citations
- 8 1.6 per fractional work
- Top-10% rate
- 4.1% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Nemocnica Bory, a.s is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.
Which research topics does Nemocnica Bory, a.s publish most on?
By volume in 2022–2025: Inflammatory Bowel Disease, Systemic Lupus Erythematosus Research, Pharmaceutical studies and practices and Cell Adhesion Molecules Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Inflammatory Bowel Disease Genetics 1 works
- 2 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 3 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 4 Cell Adhesion Molecules Research Immunology and Allergy 0 works
- 5 Biosimilars and Bioanalytical Methods Immunology 0 works
- 6 Orthopaedic implants and arthroplasty Surgery 0 works
- 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 8 Microscopic Colitis Epidemiology 0 works
- 9 Hip disorders and treatments Surgery 0 works
- 10 Cerebral Venous Sinus Thrombosis Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Bratislava
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.